TrialJournal of orthopaedic surgery and research2019

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients.

Jun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.